Literature DB >> 15236750

Early events in islets and pancreatic lymph nodes in autoimmune diabetes.

Caroline Aspord1, Sophie Rome, Charles Thivolet.   

Abstract

The specific contributions of islet cell microenvironment during the development of autoimmune type 1 diabetes remain unclear. The aims of this study were to identify early immune-driven abnormalities in islets and pancreatic lymph nodes of NOD mice by cDNA arrays. We compared gene expression profiles of purified islets and pancreatic lymph nodes of 4-week-old NOD mice to NOD-SCID and BALB/c mice. To further characterize the networks implicated in beta-cell destruction, we also performed a time-course analysis using islets and pancreatic lymph nodes of NOD mice from 2 to 25 weeks of age. We found consistent changes by cDNA arrays and RT-PCR analyses among islet genes before the detection of CD3+ T cells in the islet periphery associated with dendritic cell attraction, lymphocyte homing, and apoptosis. In contrast to IL-1, TYNFSF13B and osteopontin genes which were specifically activated, the immunoregulatory cytokine IL-11 was poorly detected in NOD islets and pancreatic lymph nodes. Genes involved in angiogenesis were also specifically activated in NOD islets of 2 and 4 weeks of age. The present time-course macroarray and RT-PCR analyses provides a detailed picture of the different genes involved in autoimmune diabetes and illustrates the importance of islet cell microenvironment that prepares the late beta-cell destruction. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15236750     DOI: 10.1016/j.jaut.2004.03.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  13 in total

1.  EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1γ to pancreatic islets.

Authors:  Katherine S Blevins; Ji Hoon Jeong; Mei Ou; Jonathan H Brumbach; Sung Wan Kim
Journal:  J Control Release       Date:  2011-10-28       Impact factor: 9.776

2.  Early differences in islets from prediabetic NOD mice: combined microarray and proteomic analysis.

Authors:  Inne Crèvecoeur; Valborg Gudmundsdottir; Saurabh Vig; Fernanda Marques Câmara Sodré; Wannes D'Hertog; Ana Carolina Fierro; Leentje Van Lommel; Conny Gysemans; Kathleen Marchal; Etienne Waelkens; Frans Schuit; Søren Brunak; Lut Overbergh; Chantal Mathieu
Journal:  Diabetologia       Date:  2017-01-12       Impact factor: 10.122

Review 3.  Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

4.  The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.

Authors:  E Aboumrad; A M Madec; C Thivolet
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

Review 5.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

6.  Polymeric delivery of therapeutic RAE-1 plasmid to the pancreatic islets for the prevention of type 1 diabetes.

Authors:  Wan Seok Joo; Ji Hoon Jeong; Kihoon Nam; Katherine S Blevins; Mohamed E Salama; Sung Wan Kim
Journal:  J Control Release       Date:  2012-08-14       Impact factor: 9.776

Review 7.  Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

8.  Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Howard L Weiner
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

9.  Immunocytochemical localization of glucose 6-phosphatase and cytosolic phosphoenolpyruvate carboxykinase in gluconeogenic tissues reveals unsuspected metabolic zonation.

Authors:  Fabienne Rajas; Hélène Jourdan-Pineau; Anne Stefanutti; Elham Abou Mrad; Patrick B Iynedjian; Gilles Mithieux
Journal:  Histochem Cell Biol       Date:  2007-01-09       Impact factor: 2.531

10.  Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus.

Authors:  Z Karamizadeh; E Kamali Sarvestani; F Saki; H Karamifar; G H Amirhakimi; M H Namavar Shooshtarian; S Ashkani-Esfahani
Journal:  J Endocrinol Invest       Date:  2013-09-27       Impact factor: 5.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.